List of Tables
    Table 1. Anti-Infective Medications CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Anti-Infective Medications Market Trends
    Table 3. Anti-Infective Medications Market Drivers
    Table 4. Anti-Infective Medications Market Challenges
    Table 5. Anti-Infective Medications Market Restraints
    Table 6. Global Anti-Infective Medications Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Anti-Infective Medications Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Anti-Infective Medications Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Anti-Infective Medications Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Anti-Infective Medications Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Anti-Infective Medications Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Anti-Infective Medications Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Anti-Infective Medications Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Anti-Infective Medications Sales Share by Manufacturer, 2017-2022
    Table 15. Global Anti-Infective Medications Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Anti-Infective Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Anti-Infective Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Medications as of 2021)
    Table 18. Top Players of Anti-Infective Medications in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Anti-Infective Medications Product Type
    Table 20. Date of International Manufacturers Enter into Anti-Infective Medications Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Anti-Infective Medications Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Anti-Infective Medications Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Anti-Infective Medications Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Anti-Infective Medications Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Anti-Infective Medications Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Anti-Infective Medications Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Anti-Infective Medications Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Anti-Infective Medications Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Anti-Infective Medications Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Anti-Infective Medications Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Anti-Infective Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Anti-Infective Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Anti-Infective Medications Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Anti-Infective Medications Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Anti-Infective Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Anti-Infective Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Anti-Infective Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Anti-Infective Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Anti-Infective Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Anti-Infective Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Abbott Corporation Information
    Table 43. Abbott Description and Business Overview
    Table 44. Abbott Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Abbott Anti-Infective Medications Product
    Table 46. Abbott Recent Development
    Table 47. Astellas Pharma Corporation Information
    Table 48. Astellas Pharma Description and Business Overview
    Table 49. Astellas Pharma Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Astellas Pharma Product
    Table 51. Astellas Pharma Recent Development
    Table 52. Bayer Corporation Information
    Table 53. Bayer Description and Business Overview
    Table 54. Bayer Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Bayer Product
    Table 56. Bayer Recent Development
    Table 57. Bristol-Myers Squibb Corporation Information
    Table 58. Bristol-Myers Squibb Description and Business Overview
    Table 59. Bristol-Myers Squibb Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Bristol-Myers Squibb Product
    Table 61. Bristol-Myers Squibb Recent Development
    Table 62. Daiichi Sankyo Corporation Information
    Table 63. Daiichi Sankyo Description and Business Overview
    Table 64. Daiichi Sankyo Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Daiichi Sankyo Product
    Table 66. Daiichi Sankyo Recent Development
    Table 67. GlaxoSmithKline Corporation Information
    Table 68. GlaxoSmithKline Description and Business Overview
    Table 69. GlaxoSmithKline Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. GlaxoSmithKline Product
    Table 71. GlaxoSmithKline Recent Development
    Table 72. Merck Corporation Information
    Table 73. Merck Description and Business Overview
    Table 74. Merck Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Merck Product
    Table 76. Merck Recent Development
    Table 77. Novartis Corporation Information
    Table 78. Novartis Description and Business Overview
    Table 79. Novartis Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Novartis Product
    Table 81. Novartis Recent Development
    Table 82. Pfizer Corporation Information
    Table 83. Pfizer Description and Business Overview
    Table 84. Pfizer Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Pfizer Product
    Table 86. Pfizer Recent Development
    Table 87. Roche Corporation Information
    Table 88. Roche Description and Business Overview
    Table 89. Roche Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Roche Product
    Table 91. Roche Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Anti-Infective Medications Customers List
    Table 95. Anti-Infective Medications Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Infective Medications Product Picture
    Figure 2. Global Anti-Infective Medications Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Anti-Infective Medications Market Size 2017-2028 (US$ Million)
    Figure 4. Global Anti-Infective Medications Sales 2017-2028 (K Units)
    Figure 5. United States Anti-Infective Medications Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Anti-Infective Medications Market Size 2017-2028 (US$ Million)
    Figure 7. United States Anti-Infective Medications Sales 2017-2028 (K Units)
    Figure 8. United States Anti-Infective Medications Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Anti-Infective Medications Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Anti-Infective Medications Report Years Considered
    Figure 11. Product Picture of Antivirals
    Figure 12. Product Picture of Antibacterials
    Figure 13. Product Picture of Antifungals
    Figure 14. Global Anti-Infective Medications Market Share by Type in 2022 & 2028
    Figure 15. Global Anti-Infective Medications Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Anti-Infective Medications Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Anti-Infective Medications Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Anti-Infective Medications Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Anti-Infective Medications Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Anti-Infective Medications Market Share by Type in 2022 & 2028
    Figure 21. United States Anti-Infective Medications Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Anti-Infective Medications Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Anti-Infective Medications Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Anti-Infective Medications Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Anti-Infective Medications Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Hospital Pharmacies
    Figure 27. Product Picture of Online Pharmacies
    Figure 28. Product Picture of Retail Pharmacies
    Figure 29. Global Anti-Infective Medications Market Share by Application in 2022 & 2028
    Figure 30. Global Anti-Infective Medications Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Anti-Infective Medications Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Anti-Infective Medications Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Anti-Infective Medications Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Anti-Infective Medications Price by Application (2017-2028) & (USD/Unit)
    Figure 35. United States Anti-Infective Medications Market Share by Application in 2022 & 2028
    Figure 36. United States Anti-Infective Medications Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Anti-Infective Medications Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Anti-Infective Medications Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Anti-Infective Medications Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Anti-Infective Medications Price by Application (2017-2028) & (USD/Unit)
    Figure 41. North America Anti-Infective Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Anti-Infective Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Anti-Infective Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Anti-Infective Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Anti-Infective Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Anti-Infective Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Anti-Infective Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Anti-Infective Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Anti-Infective Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Anti-Infective Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Anti-Infective Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Anti-Infective Medications Value Chain
    Figure 75. Anti-Infective Medications Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed